By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – DiagnoCure this week said that it has retained the financial services firm JMP Securities to help it increase business for its DiagnoCure Oncology Laboratories.

In a statement, Yves Fradet, president and chief medical officer of DiagnoCure, added that JMP will help the company "determine the most effective method to roll out our colorectal cancer disease management program."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.